chr6-33315989-T-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_005453.5(ZBTB22):āc.928A>Gā(p.Thr310Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.533 in 1,613,586 control chromosomes in the GnomAD database, including 230,792 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005453.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZBTB22 | NM_005453.5 | c.928A>G | p.Thr310Ala | missense_variant | 2/2 | ENST00000431845.3 | |
ZBTB22 | NM_001145338.2 | c.928A>G | p.Thr310Ala | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZBTB22 | ENST00000431845.3 | c.928A>G | p.Thr310Ala | missense_variant | 2/2 | 1 | NM_005453.5 | P1 | |
ZBTB22 | ENST00000418724.1 | c.928A>G | p.Thr310Ala | missense_variant | 2/2 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.539 AC: 81662AN: 151640Hom.: 22160 Cov.: 30
GnomAD3 exomes AF: 0.540 AC: 135569AN: 251230Hom.: 37224 AF XY: 0.547 AC XY: 74276AN XY: 135874
GnomAD4 exome AF: 0.532 AC: 777628AN: 1461828Hom.: 208597 Cov.: 84 AF XY: 0.536 AC XY: 389921AN XY: 727216
GnomAD4 genome AF: 0.539 AC: 81752AN: 151758Hom.: 22195 Cov.: 30 AF XY: 0.541 AC XY: 40124AN XY: 74138
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at